Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romina Verardo

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of Clinical Medicine|March 25, 2022
Hypersensitivity Myocarditis after COVID-19 mRNA VaccinationAndrea Frustaci, Romina Verardo, Nicola Galea, et al.
Biomedicines|August 29, 2024
Cardiomyocyte Regeneration in Human MyocarditisAndrea Frustaci, Eleonora Foglio, Federica Limana, et al.
European Heart Journal|February 21, 2007
Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deteriorationAndrea Frustaci, Romina Verardo, Marina Caldarulo, et al.
Journal of Clinical Medicine|September 23, 2022
Downregulation of Mannose-6-Phosphate Receptors in Fabry Disease Cardiomyopathy: A Potential Target for Enzyme Therapy EnhancementAndrea Frustaci, Romina Verardo, Rossella Scialla, et al.
ESC Heart Failure|September 3, 2022
Removal of cardiac AL amyloid with positive remodelling of cardiomyocytes and of restrictive cardiomyopathyAndrea Frustaci, Romina Verardo, Nicola Galea, et al.
Journal of Clinical Medicine|June 28, 2023
Interleukin-17A-Correlated Myocarditis in Patients with Psoriasis: Cardiac Recovery following Secukinumab AdministrationAndrea Frustaci, Nicola Galea, Lorenzo Dominici, et al.
ESC Heart Failure|October 23, 2020
Myocarditis and intramural coronary vasculitis in polyarteritis nodosa: an unusual treatable form of heart failureCristina Chimenti, Maria Alfarano, Federica Toto, et al.
Journal of Cardiac Failure|July 3, 2007
Increased brain natriuretic peptide secretion is a marker of disease progression in nonobstructive hypertrophic cardiomyopathyMaurizio Pieroni, Fulvio Bellocci, Tommaso Sanna, et al.
Circulation. Arrhythmia and Electrophysiology|June 7, 2015
Pathology and function of conduction tissue in Fabry disease cardiomyopathyAndrea Frustaci, Emanuela Morgante, Matteo A Russo, et al.
European Journal of Heart Failure|April 4, 2017
Myocardial expression of Toll-like receptor 4 predicts the response to immunosuppressive therapy in patients with virus-negative chronic inflammatory cardiomyopathyCristina Chimenti, Romina Verardo, Fernanda Scopelliti, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|March 25, 2022
Hypersensitivity Myocarditis after COVID-19 mRNA VaccinationAndrea Frustaci, Romina Verardo, Nicola Galea, et al.
Biomedicines|August 29, 2024
Cardiomyocyte Regeneration in Human MyocarditisAndrea Frustaci, Eleonora Foglio, Federica Limana, et al.
European Heart Journal|February 21, 2007
Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deteriorationAndrea Frustaci, Romina Verardo, Marina Caldarulo, et al.
Journal of Clinical Medicine|September 23, 2022
Downregulation of Mannose-6-Phosphate Receptors in Fabry Disease Cardiomyopathy: A Potential Target for Enzyme Therapy EnhancementAndrea Frustaci, Romina Verardo, Rossella Scialla, et al.
ESC Heart Failure|September 3, 2022
Removal of cardiac AL amyloid with positive remodelling of cardiomyocytes and of restrictive cardiomyopathyAndrea Frustaci, Romina Verardo, Nicola Galea, et al.
Journal of Clinical Medicine|June 28, 2023
Interleukin-17A-Correlated Myocarditis in Patients with Psoriasis: Cardiac Recovery following Secukinumab AdministrationAndrea Frustaci, Nicola Galea, Lorenzo Dominici, et al.
ESC Heart Failure|October 23, 2020
Myocarditis and intramural coronary vasculitis in polyarteritis nodosa: an unusual treatable form of heart failureCristina Chimenti, Maria Alfarano, Federica Toto, et al.
Journal of Cardiac Failure|July 3, 2007
Increased brain natriuretic peptide secretion is a marker of disease progression in nonobstructive hypertrophic cardiomyopathyMaurizio Pieroni, Fulvio Bellocci, Tommaso Sanna, et al.
Circulation. Arrhythmia and Electrophysiology|June 7, 2015
Pathology and function of conduction tissue in Fabry disease cardiomyopathyAndrea Frustaci, Emanuela Morgante, Matteo A Russo, et al.
European Journal of Heart Failure|April 4, 2017
Myocardial expression of Toll-like receptor 4 predicts the response to immunosuppressive therapy in patients with virus-negative chronic inflammatory cardiomyopathyCristina Chimenti, Romina Verardo, Fernanda Scopelliti, et al.
Pageof 5